HomeTagsDermacyte® Matrix

Dermacyte® Matrix

Merakris Therapeutics Announces the Commercial Launch of Dermacyte® Matrix and CMS Assignment of an HCPCS Code for Use as a Skin Graft Substitute

This is another milestone for Merakris Therapeutics that the largest healthcare payer, CMS, has recognized Dermacyte Matrix with a unique reimbursement code.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version